(Q43270612)

English

Pharmacokinetics, safety, and tolerability of phentermine in healthy participants receiving taranabant, a novel cannabinoid-1 receptor (CB1R) inverse agonist

scientific article published in October 2009

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Pharmacokinetics, safety, and tolerability of phentermine in healthy participants receiving taranabant, a novel cannabinoid-1 receptor (CB1R) inverse agonist (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

0 references

0 references

cannabinoid receptor

0 references

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

Carol Addy

1

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Patricia Jumes

2

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Kimberly Rosko

3

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Susie Li

4

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Hankun Li

5

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Andrea Maes

6

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Amy O Johnson-Levonas

7

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Jeffrey Chodakewitz

8

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

S Aubrey Stoch

9

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

John A Wagner

10

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

publication date

1 October 2009

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

The Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

49

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

1228-1238

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Pharmacological treatment of the overweight patient

1 reference

https://api.crossref.org/works/10.1177%2F0091270009341651

21 January 2018

Dexfenfluramine, fenfluramine, and phentermine for the treatment of morbid obesity

1 reference

https://api.crossref.org/works/10.1177%2F0091270009341651

21 January 2018

Appetite suppressants and valvular heart disease

1 reference

https://api.crossref.org/works/10.1177%2F0091270009341651

21 January 2018

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

1 reference

https://api.crossref.org/works/10.1177%2F0091270009341651

21 January 2018

The cannabinoid receptors.

1 reference

https://api.crossref.org/works/10.1177%2F0091270009341651

21 January 2018

Endocannabinoids in appetite control and the treatment of obesity

1 reference

https://api.crossref.org/works/10.1177%2F0091270009341651

21 January 2018

Endogenous cannabinoids: a new target in the treatment of obesity

1 reference

https://api.crossref.org/works/10.1177%2F0091270009341651

21 January 2018

The acyclic CB1R inverse agonist taranabant mediates weight loss by increasing energy expenditure and decreasing caloric intake

1 reference

https://api.crossref.org/works/10.1177%2F0091270009341651

21 January 2018

Antiobesity efficacy of a novel cannabinoid-1 receptor inverse agonist, N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-[[5-(trifluoromethyl)pyridin-2-yl]oxy]propanamide (MK-0364), in rodents

1 reference

https://api.crossref.org/works/10.1177%2F0091270009341651

21 January 2018

Multiple-dose pharmacokinetics, pharmacodynamics, and safety of taranabant, a novel selective cannabinoid-1 receptor inverse agonist, in healthy male volunteers

1 reference

https://api.crossref.org/works/10.1177%2F0091270009341651

21 January 2018

The PHQ-9: validity of a brief depression severity measure

1 reference

https://api.crossref.org/works/10.1177%2F0091270009341651

21 January 2018

The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms

1 reference

https://api.crossref.org/works/10.1177%2F0091270009341651

21 January 2018

The use of visual analog scales in mood disorders: a critical review

1 reference

https://api.crossref.org/works/10.1177%2F0091270009341651

21 January 2018

Identifiers

10.1177/0091270009341651

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43270612&oldid=2144634993"